Welcome

The Vermont Center on Behavior and Health (VCBH), led by Director Stephen T. Higgins, PhD, is an interdisciplinary research center committed to investigating relationships between personal behavior patterns (i.e., lifestyle) and risk for chronic disease and premature death. Our work has historically focused on health disparities for the most vulnerable populations, particularly among the socioeconomically disadvantaged where these risk factors are overrepresented.

 

VCBH logo

Located in Burlington, VT at the University of Vermont, Larner College of Medicine, VCBH researchers have a specific focus on understanding mechanisms underpinning risk and developing effective interventions and policies to promote healthy behavior. A common thread across VCBH research projects is the application of knowledge from the disciplines of behavioral economics and behavioral pharmacology to increase understanding of vulnerability to unhealthy behavior and the use of incentives and other behavioral and pharmacological interventions to support healthy behavior change interventions and policies.

Stay Connected with VCBH

Join our mailing list to get the latest
on news and events.

Follow us on our social media channels

Twitter icon circle Facebook icon circle LinkedIn icon YouTube Icon

Upcoming VCBH Events

Monthly Lecture Series:

November 19, 2025
Robert Scholl, PhD
University of Pennsylvania

December 10, 2025
Elias Klemperer, PhD
University of Vermont

Visit the Center on Rural Addiction

CORA_transparents

 


VCBH Career Opportunities

None at the current time. Please check back later!

VCBH News

Klemperer Interviewed about E-Cigarettes on University of Oxford Podcast

September 24, 2025 by Christopher Pung

Elias Klemperer, Ph.D., Associate Professor of Psychiatry and Psychological Science at the UVM Larner College of Medicine, was recently featured on the University of Oxford’s Let’s Talk E-Cigarettes podcast. He discussed the new evidence in e-cigarette research and his recent randomized trial of nicotine replacement therapy, or NRT (patches and lozenges). The study found that NRT was effective in promoting early smoking cessation among young adult dual users. Their secondary findings indicated that pairing NRT with support to quit both products could enhance the effects on prolonged cigarette abstinence.
Elias Klemperer, Ph.D., Associate Professor of Psychiatry and Psychological Science at the UVM Larner College of Medicine, was recently featured on the University of Oxford’s Let’s Talk E-Cigarettes podcast. He discussed the new evidence in e-cigarette research and his recent randomized trial of nicotine replacement therapy, or NRT (patches and lozenges). The study found that NRT was effective in promoting early smoking cessation among young adult dual users. Their secondary findings indicated that pairing NRT with support to quit both products could enhance the effects on prolonged cigarette abstinence. Read full story at University of Oxford Podcasts